Can surgeons improve survival in stage IV melanoma?

Paul J. Mosca, Erik Teicher, Suresh P. Nair, Barbara A. Pockaj

Research output: Contribution to journalReview article

12 Scopus citations

Abstract

Successful systemic management of stage IV melanoma continues to be elusive because of the paucity of effective therapies. This has fueled the continued interest in surgical resection. Several single-institution studies and a current, large, multi-institutional phase III trial have demonstrated a survival benefit for patients who underwent surgical resection for melanoma metastases. Incorporating these results into new approaches using multimodality treatment may enhance survival in patients with stage IV melanoma.

Original languageEnglish (US)
Pages (from-to)462-468
Number of pages7
JournalJournal of Surgical Oncology
Volume97
Issue number5
DOIs
StatePublished - Apr 1 2008

Keywords

  • Advanced disease
  • Immunotherapy
  • Metastasis
  • Surgery
  • Systemic therapy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Can surgeons improve survival in stage IV melanoma?'. Together they form a unique fingerprint.

  • Cite this